Contec Medical Systems Co Ltd (300869) - Net Assets

Latest as of September 2025: CN¥1.77 Billion CNY ≈ $258.44 Million USD

Based on the latest financial reports, Contec Medical Systems Co Ltd (300869) has net assets worth CN¥1.77 Billion CNY (≈ $258.44 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.79 Billion ≈ $408.39 Million USD) and total liabilities (CN¥1.02 Billion ≈ $149.95 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Contec Medical Systems Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥1.77 Billion
% of Total Assets	63.28%
Annual Growth Rate	23.45%
5-Year Change	18.4%
10-Year Change	533.3%
Growth Volatility	45.54

Contec Medical Systems Co Ltd - Net Assets Trend (2013–2024)

This chart illustrates how Contec Medical Systems Co Ltd's net assets have evolved over time, based on quarterly financial data. See Contec Medical Systems Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Contec Medical Systems Co Ltd (2013–2024)

The table below shows the annual net assets of Contec Medical Systems Co Ltd from 2013 to 2024. For live valuation and market cap data, see Contec Medical Systems Co Ltd stock valuation.

Year	Net Assets	Change
2024-12-31	CN¥1.86 Billion ≈ $271.80 Million	-9.16%
2023-12-31	CN¥2.04 Billion ≈ $299.22 Million	+6.04%
2022-12-31	CN¥1.93 Billion ≈ $282.18 Million	+5.95%
2021-12-31	CN¥1.82 Billion ≈ $266.33 Million	+16.01%
2020-12-31	CN¥1.57 Billion ≈ $229.57 Million	+168.99%
2019-12-31	CN¥583.23 Million ≈ $85.34 Million	+14.53%
2018-12-31	CN¥509.23 Million ≈ $74.52 Million	+14.05%
2017-12-31	CN¥446.51 Million ≈ $65.34 Million	+20.35%
2016-12-31	CN¥371.02 Million ≈ $54.29 Million	+26.50%
2015-12-31	CN¥293.29 Million ≈ $42.92 Million	+28.08%
2014-12-31	CN¥229.00 Million ≈ $33.51 Million	+25.13%
2013-12-31	CN¥183.01 Million ≈ $26.78 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Contec Medical Systems Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 839.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	CN¥892.41 Million	48.05%
Common Stock	CN¥401.80 Million	21.63%
Other Comprehensive Income	CN¥218.39 Million	11.76%
Other Components	CN¥344.82 Million	18.56%
Total Equity	CN¥1.86 Billion	100.00%

Contec Medical Systems Co Ltd Competitors by Market Cap

The table below lists competitors of Contec Medical Systems Co Ltd ranked by their market capitalization.

Company	Market Cap
2CRSI S.A. PA:AL2SI	$670.79 Million
Sprinklr Inc NYSE:CXM	$670.82 Million
Inti Bangun Sejahtera Tbk JK:IBST	$670.86 Million
2G Energy AG XETRA:2GB	$670.96 Million
Kaili Catalyst & New Materials Co. Ltd. A SHG:688269	$669.22 Million
QuinStreet Inc NASDAQ:QNST	$669.11 Million
Alpargatas S.A SA:ALPA3	$668.85 Million
Guangdong Huafeng New Energy Technology Co Ltd SHE:002806	$668.80 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Contec Medical Systems Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 2,044,796,689 to 1,857,415,749, a change of -187,380,940 (-9.2%).
Net loss of 77,902,564 reduced equity.
Dividend payments of 127,716,768 reduced retained earnings.
Other comprehensive income increased equity by 11,062,148.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CN¥-77.90 Million	-4.19%
Dividends Paid	CN¥127.72 Million	-6.88%
Other Comprehensive Income	CN¥11.06 Million	+0.6%
Other Changes	CN¥7.18 Million	+0.39%
Total Change	CN¥-	-9.16%

Book Value vs Market Value Analysis

This analysis compares Contec Medical Systems Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.81x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 5.98x to 2.81x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2013-12-31	CN¥1.91	CN¥11.40	x
2014-12-31	CN¥2.27	CN¥11.40	x
2015-12-31	CN¥0.86	CN¥11.40	x
2016-12-31	CN¥1.08	CN¥11.40	x
2017-12-31	CN¥1.22	CN¥11.40	x
2018-12-31	CN¥1.40	CN¥11.40	x
2019-12-31	CN¥1.45	CN¥11.40	x
2020-12-31	CN¥3.90	CN¥11.40	x
2021-12-31	CN¥4.53	CN¥11.40	x
2022-12-31	CN¥4.72	CN¥11.40	x
2023-12-31	CN¥4.93	CN¥11.40	x
2024-12-31	CN¥4.05	CN¥11.40	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Contec Medical Systems Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -4.19%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -16.24%
• Asset Turnover: 0.18x
• Equity Multiplier: 1.47x
Recent ROE (-4.19%) is below the historical average (18.06%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2013	29.39%	25.18%	0.78x	1.49x	CN¥35.49 Million
2014	23.78%	21.60%	0.83x	1.33x	CN¥31.56 Million
2015	20.98%	21.63%	0.67x	1.44x	CN¥32.20 Million
2016	27.89%	23.41%	0.89x	1.33x	CN¥66.39 Million
2017	17.26%	19.37%	0.72x	1.24x	CN¥32.41 Million
2018	12.18%	17.10%	0.63x	1.13x	CN¥11.11 Million
2019	12.65%	19.05%	0.57x	1.16x	CN¥15.46 Million
2020	39.10%	43.78%	0.67x	1.34x	CN¥456.51 Million
2021	19.36%	38.78%	0.33x	1.53x	CN¥170.35 Million
2022	10.17%	27.55%	0.19x	1.94x	CN¥3.37 Million
2023	8.11%	22.19%	0.23x	1.57x	CN¥-38.71 Million
2024	-4.19%	-16.24%	0.18x	1.47x	CN¥-263.64 Million

Industry Comparison

This section compares Contec Medical Systems Co Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $1,337,671,338
Average return on equity (ROE) among peers: 16.49%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Contec Medical Systems Co Ltd (300869)	CN¥1.77 Billion	29.39%	0.58x	$670.28 Million
Shanghai Kehua Bio-Engineering Co Ltd (002022)	$1.09 Billion	22.08%	0.18x	$371.06 Million
Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223)	$154.18 Million	20.46%	1.55x	$3.63 Billion
Double Medical Technology Inc (002901)	$2.59 Billion	26.01%	0.31x	$2.56 Billion
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932)	$115.39 Million	30.85%	0.16x	$506.97 Million
Lepu Medical Tech Beijing (300003)	$2.89 Billion	12.49%	0.08x	$3.19 Billion
INKON Life Technology Co Ltd (300143)	$2.07 Billion	2.43%	0.27x	$764.39 Million
Edan Instruments Inc (300206)	$1.16 Billion	1.16%	0.17x	$1.15 Billion
Guangdong Biolight Meditech Co Ltd (300246)	$89.93 Million	36.68%	0.42x	$735.30 Million
Beijing Leadman Biochemistry Co Ltd (300289)	$1.98 Billion	1.13%	0.19x	$467.29 Million
Sinocare Inc (300298)	$1.24 Billion	11.58%	0.08x	$1.17 Billion

About Contec Medical Systems Co Ltd

SHE:300869 China Medical Devices

Market Cap

$670.28 Million

CN¥4.58 Billion CNY

Market Cap Rank

#10952 Global

#3072 in China

Share Price

CN¥11.40

Change (1 day)

+5.56%

52-Week Range

CN¥10.71 - CN¥20.70

All Time High

CN¥162.41